home.aspx

 
.

MEETING OF THE MEDICAL IMAGING DRUGS ADVISORY COMMITTEE MEETING ANNOUNCEMENT

April 23-23, 2020
Maryland, USA
SHARESHARESHARE
The committee will discuss new drug application 212123, flortaucipir F18 intravenous injection, a radioactive diagnostic agent, submitted by Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, for positron emission tomography imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles of Alzheimer’s disease.